XOMA Royalty Corporation (XOMA) is a Healthcare · Biotechnology company listed on NASDAQ. Price $40.17 (-9.16%), Market cap $0.52B, P/E ratio 26.46, 52-week low–high $22.89 ~ $42.00.
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty
Financial statements, price targets, institutional (13F) holdings and related news for XOMA Royalty Corporation are updated in real time on BlackAll Trade.
XOMA Royalty Corporation trades at $40.17 (-9.16%). Real-time quotes and charts are available on BlackAll Trade.
XOMA Royalty Corporation has a market cap of about $0.52B. Its P/E ratio is 26.46.
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential mileston